Literature DB >> 10804400

[Differential diagnosis of infective spondylodiscitis and erosive degenerative disk disease].

P Champsaur1, C Parlier-Cuau, V Juhan, V Daumen-Legré, C Chagnaud, P Lafforgue, J D Laredo, M Kasbarian.   

Abstract

PURPOSE: To assess the value of imaging in the differential diagnosis of erosive intervertebral osteochondrosis (EIVO) versus infectious discitis (ID).
MATERIALS AND METHODS: Twelve cases of EIVO and 30 cases of ID were reviewed to define the usefull signs for differential diagnosis on plain films, CT, and MR.
RESULTS: No single sign is sufficient, but the association of several signs is suggestive of EIVO: discal vacuum phenomenom, well-defined sclerosis and erosions of vertebral endplates, high signal strip surrounding low signal of vertebral endplates on T1-weighted images.
CONCLUSION: Imaging is helpful in difficult differential diagnosis of EIVO versus ID.

Entities:  

Mesh:

Year:  2000        PMID: 10804400

Source DB:  PubMed          Journal:  J Radiol        ISSN: 0221-0363


  3 in total

Review 1.  Vertebral endplate signal changes (Modic change): a systematic literature review of prevalence and association with non-specific low back pain.

Authors:  Tue Secher Jensen; Jaro Karppinen; Joan S Sorensen; Jaakko Niinimäki; Charlotte Leboeuf-Yde
Journal:  Eur Spine J       Date:  2008-09-12       Impact factor: 3.134

2.  Progressive flaccid paraparesis with albuminocytologic dissociation: It's not always Gullain-Barre syndrome.

Authors:  Dimitrios Nouvakis; Konstantinos S Natsis; Antonia Tsika; Georgia Kourtesi; Evangelos Papamichalis; Harilaos Mourtzinos
Journal:  J Spinal Cord Med       Date:  2018-06-25       Impact factor: 1.985

3.  Efficacy and safety of pamidronate in Modic type 1 changes: study protocol for a prospective randomized controlled clinical trial.

Authors:  Stella Cecchetti; Bruno Pereira; Antoine Roche; Christophe Deschaumes; Dihya Abdi; Emmanuel Coudeyre; Jean-Jacques Dubost; Sylvain Mathieu; Sandrine Malochet-Guinamand; Anne Tournadre; Marion Couderc; Marielle Vayssade; Coline Daron; Martin Soubrier
Journal:  Trials       Date:  2014-04-09       Impact factor: 2.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.